Atlas Venture Associates Opportunity II, LP
SEC CIK 1935814 · EDGAR
BoughtSold
Most active insiders at KRRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FORMELA JEAN FRANCOIS | Dir | — | $5.16M |
| 2 | Yang Rick | 10% | $2.30M | — |
| 3 | New Enterprise Associates 17, L.P. | 10% | $2.30M | — |
| 4 | Chang Carmen | 10% | $2.30M | — |
| 5 | Makhzoumi Mohamad | 10% | $2.30M | — |
| 6 | Florence Anthony A. Jr. | 10% | $2.30M | — |
| 7 | Walker Paul Edward | 10% | $2.30M | — |
| 8 | Mathers Edward T | 10% | $2.30M | — |
| 9 | BASKETT FOREST | 10% | $2.30M | — |
| 10 | SANDELL SCOTT D | 10% | $2.30M | — |
Atlas Venture Associates Opportunity II, LP made no open-market trades at KRRO in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-23 | 2024-04-22 | KRRO | Korro Bio, Inc. | Atlas Venture Associates Opportunity II, LP | 10% | P - Purchase | $56.00 | +17.9K | 195.1K | +10% | +$1000.0K | |
| I | 2024-03-05 | 2024-03-01 | DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% | S - Sale | $30.05 | -17.1K | 847.4K | -2% | -$513.8K |
| 2024-03-05 | 2024-03-01 | DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% | S - Sale | $30.05 | -29.4K | 1.46M | -2% | -$884.5K |
Purchase Sale Sale after option exercise All abbreviations